About
Vaccines
Areas of Focus
Categories
VaccineAustria
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
336
By Phase
PHASE2: 1PHASE1: 2
By Status
RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07049159Lead Sponsor
Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old
PHASE2Recruiting
72 participants
Started: Jun 30, 2025 · Completed: May 23, 2027
NCT05987488Lead Sponsor
ShigETEC Vaccine Study in Bangladesh
PHASE1Recruiting
180 participants
Started: Nov 26, 2023 · Completed: Dec 31, 2025
NCT05409196Lead Sponsor
Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults
PHASE1Completed
84 participants
Started: Sep 16, 2020 · Completed: Jun 21, 2021
Locations (1)
Headquarters
Vienna, Austria
Map
Loading map...